首页> 外文学位 >Pharmacokinetics of cefazolin in skin following iontophoretic administration in a rabbit model.
【24h】

Pharmacokinetics of cefazolin in skin following iontophoretic administration in a rabbit model.

机译:在兔模型中进行离子电渗疗法后,头孢唑林在皮肤中的药代动力学。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this thesis was to study the pharmacokinetics of cefazolin in skin following iontophoretic administration by using a stainless-steel patch. Cefazolin is a first generation cephalosporin antibiotic.;FDA labeled indication of cefazolin includes treatment of skin infections. The pharmacokinetic behavior of cefazolin in skin is poorly studied. Cefazolin is mainly used to treat bacterial infections of the skin. It has been observed that cefazolin sodium is used for skin or soft tissue infection, cutaneous bacillus anthracis and bacterial infection caused due to S. aureus (including (beta-lactamase-producing strains), S. pyogenes, and other strains of streptococci. There is no topical or transdermal preparation of cetazolin in the market. The main purpose of my thesis was to find out whether the cefazolin can be administered by iontophoresis and can each up to effective concentration against the Staphylococcus aureus or Streptococcus pyogenes. If the concentration in the skin reaches to MIC (Minimum Inhibitory Concentration) then there are chances that drug may have further dermatological action. The MIC of cefazolin in the skin is 0.25 to 1.0 mug/ml for the infection cause by Staphylococcus aureus and Streptococcus pyogenes and 1.0 to 4.0 mug/ml for the infection cause by E. coli. To monitor target site concentrations in rabbit skin microdialysis technique was used, which allows sequential sampling over time.;Iontophoresis is a penetration enhancer technique that uses a mild electrical current to increase the penetration of charged ions through the skin. Since cefazolin is ionized at physiological pH it looks like a suitable candidate for iontophoretic delivery. Microdialysis is a semi-invasive separation technique that allows the sampling or the delivery of molecules in vivo, according to the concentration gradient between the solution perfusing the probe and the extracellular fluid surrounding it. Owing to selective access to the target site for most anti-infective drugs, microdialysis satisfies regulatory requirements for pharmacokinetic distribution studies and has become a reference technique for tissue distribution studies.;The HPLC method selected and validated for the cefazolin in microdialysis samples consisted of a reversed phase C18 column, flow rate of 0.8 ml/min and a detection wavelength of 273 nm. Mobile phase used for microdialysis consisted of 90% 0.05 M phosphate buffer (pH 5) and 10% Acetonitrile. The retention time was 8.26 min. The calibration curves for microdialysis samples were linear in the range of 0.5 to 50 mug/ml with a correlation coefficient larger than 0.99. The lower limit of quantification (LLOQ) was 0.5 mug/ml. The kinetics of cefazolin was investigated in 3 female pathogen-free New Zealand albino rabbits. Microdialysis probes were implanted into the upper dorsal shaved skin of a tranquilized rabbit and perfused with lactated Ringer's solution. Patches donated by Dr. Phillip Friden (Transport Pharmaceuticals, Framingham, MA) were used to deliver cefazolin for 60 min at different current densities (50, 75, 100, and 125 muA/cm2) on different occasions in a randomized cross-over experimental design in same dose. Microdialysis samples were collected at selected time intervals. Retrodialysis was performed at the start of each experiment to assess probe recovery and correct the dialysate concentration to reflect the actual interstitial fluid concentration.;The results show that measurable cefazolin concentrations were reached immediately after the onset of the current in the skin. There is not a significant concentration of cefazolin in skin has been reached for current densities 50 muA/cm2, but it reaches to MIC for a considerable time for current densities of 75, 100, and 125 muA/cm2. Though there was no so considerable difference in Cmax and AUC across the different current densities of 75, 100, and 125 muA/cm2, this study indicates the possibility of transdermal delivery of cefazolin by iontophoresis.
机译:本文的目的是研究使用不锈钢贴片进行离子电渗疗法后头孢唑林在皮肤中的药代动力学。头孢唑林是第一代头孢菌素抗生素; FDA标记的头孢唑林适应症包括皮肤感染的治疗。头孢唑林在皮肤中的药代动力学行为研究很少。头孢唑林主要用于治疗皮肤细菌感染。已经观察到,头孢唑啉钠用于皮肤或软组织感染,炭疽杆菌和因金黄色葡萄球菌(包括(产生β-内酰胺酶的菌株),化脓性链球菌和其他链球菌引起的细菌感染)。在市场上没有塞他唑林的局部或透皮制剂,本文的主要目的是确定头孢唑林是否可以通过离子电渗疗法进行给药,并且每种药物都可以有效抵抗金黄色葡萄球菌或化脓性链球菌。如果皮肤达到最小抑菌浓度(MIC),则药物可能具有进一步的皮肤病学作用。由于金黄色葡萄球菌和化脓性链球菌引起的感染,皮肤中头孢唑林的MIC为0.25至1.0杯/毫升,而化脓性链球菌则为1.0至4.0杯。 / ml用于检测大肠埃希菌引起的感染,为了监测兔皮肤微透析技术中的目标部位浓度,可以连续进行离子电渗疗法是一种渗透增强剂技术,该技术使用适度的电流来增加带电离子穿过皮肤的渗透性。由于头孢唑啉在生理pH下被离子化,因此看起来像是离子电渗疗法的合适候选者。微透析是一种半侵入式分离技术,可根据在探针中浸入的溶液与其周围的细胞外液之间的浓度梯度,在体内对分子进行采样或递送。由于大多数抗感染药物可以选择性地进入靶位点,因此微透析满足了药代动力学分布研究的监管要求,并已成为组织分布研究的参考技术。;为微透析样品中的头孢唑啉选择并验证的HPLC方法包括:反相C18柱,流速0.8 ml / min,检测波长273 nm。用于微透析的流动相由90%0.05 M磷酸盐缓冲液(pH 5)和10%乙腈组成。保留时间为8.26分钟。微透析样品的校准曲线在0.5至50杯/毫升的范围内呈线性,相关系数大于0.99。定量下限(LLOQ)为0.5马克杯/毫升。在3只雌性无病原体的新西兰白化兔子中研究了头孢唑林的动力学。将微透析探针植入一只平静的兔子的上背部剃毛皮肤,并用乳酸林格氏液灌注。由Phillip Friden博士(马萨诸塞州弗雷明汉,Transport Pharmaceuticals)捐赠的贴片用于在随机交叉实验中,以不同电流密度(50、75、100和125μA/ cm2)在不同场合下以头孢唑啉递送60分钟。设计相同的剂量。在选定的时间间隔收集微透析样品。在每个实验开始时进行透析,以评估探针的回收率并校正透析液的浓度以反映实际的间质液浓度。结果表明,皮肤中电流开始后立即达到可测量的头孢唑林浓度。电流密度为50μA/ cm2时,头孢唑啉在皮肤中的浓度未达到显着水平,但电流密度为75、100和125μA/ cm2时,其达到MIC的时间相当长。尽管在75、100和125μA/ cm2的不同电流密度下,Cmax和AUC差异不大,但这项研究表明通过离子电渗疗法透皮递送头孢唑林的可能性。

著录项

  • 作者

    Patel, Pranav.;

  • 作者单位

    Long Island University, The Brooklyn Center.;

  • 授予单位 Long Island University, The Brooklyn Center.;
  • 学科 Health Sciences Pharmacy.
  • 学位 M.S.
  • 年度 2009
  • 页码 73 p.
  • 总页数 73
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号